Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Chiara Fornabaio et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registryTommaso Clemente, Flavia Balena, Sara Diotallevi et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryDaniele Armenia, Silvia Magnani, Giovanni Marchegiani et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 0